GSK Investigational Site
Cleveland, Ohio 44195
We've found
5 trials
at this facility
Hypereosinophilic Syndrome Clinical Trial
Updated: 12/31/1969
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Obstetric Labour, Premature Clinical Trial
Updated: 12/31/1969
Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 12/31/1969
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Respiratory Syncytial Virus Infections Clinical Trial
Updated: 12/31/1969
A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Respiratory Syncytial Virus Infections Clinical Trial
Updated: 12/31/1969
Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials